Bangladesh: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Bangladesh

The Bangladeshi prophylactic medicaments containing insulin market contracted to $X in 2022, waning by -5.8% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Over the period under review, consumption continues to indicate a perceptible shrinkage. Prophylactic medicaments containing insulin consumption peaked at $X in 2012; however, from 2013 to 2022, consumption failed to regain momentum.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Bangladesh

Prophylactic medicaments containing insulin exports from Bangladesh soared to X kg in 2022, rising by 151% against the year before. Overall, exports saw resilient growth. The growth pace was the most rapid in 2019 when exports increased by 243%. The exports peaked at X kg in 2020; however, from 2021 to 2022, the exports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin exports reduced sharply to $X in 2022. Over the period under review, exports showed a remarkable increase. The growth pace was the most rapid in 2019 with an increase of 193% against the previous year. Over the period under review, the exports attained the peak figure at $X in 2021, and then declined dramatically in the following year.

Exports by Country

The Philippines (X kg) was the main destination for prophylactic medicaments containing insulin exports from Bangladesh, accounting for a 83% share of total exports. Moreover, prophylactic medicaments containing insulin exports to the Philippines exceeded the volume sent to the second major destination, Kenya (X kg), tenfold.

From 2012 to 2022, the average annual growth rate of volume to the Philippines totaled +63.1%. Exports to the other major destinations recorded the following average annual rates of exports growth: Kenya (-8.2% per year) and Belize (+28.7% per year).

In value terms, the Philippines ($X) remains the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Bangladesh, comprising 76% of total exports. The second position in the ranking was taken by Kenya ($X), with a 13% share of total exports.

From 2012 to 2022, the average annual growth rate of value to the Philippines stood at +39.8%. Exports to the other major destinations recorded the following average annual rates of exports growth: Kenya (-5.6% per year) and Belize (+22.4% per year).

Export Prices by Country

The average prophylactic medicaments containing insulin export price stood at $X per ton in 2022, waning by -66.9% against the previous year. Overall, the export price saw a deep reduction. The pace of growth appeared the most rapid in 2021 an increase of 282% against the previous year. As a result, the export price attained the peak level of $X per ton, and then declined sharply in the following year.

There were significant differences in the average prices for the major overseas markets. In 2022, amid the top suppliers, the country with the highest price was Kenya ($X per ton), while the average price for exports to the Philippines ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Kenya (+2.8%), while the prices for the other major destinations experienced a decline.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Bangladesh

In 2022, the amount of medicaments containing insulin but not antibiotics in measured doses imported into Bangladesh dropped to X tons, which is down by -6.5% compared with the previous year's figure. Overall, imports saw a perceptible decrease. The growth pace was the most rapid in 2015 when imports increased by 144%. Imports peaked at X tons in 2012; however, from 2013 to 2022, imports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin imports dropped to $X in 2022. In general, imports recorded a mild decrease. The pace of growth was the most pronounced in 2019 with an increase of 107%. Imports peaked at $X in 2012; however, from 2013 to 2022, imports stood at a somewhat lower figure.

Imports by Country

The United States (X tons), France (X tons) and Denmark (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to Bangladesh, together accounting for 68% of total imports.

From 2012 to 2022, the biggest increases were recorded for the United States (with a CAGR of +42.5%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, the largest prophylactic medicaments containing insulin suppliers to Bangladesh were Denmark ($X), the United States ($X) and France ($X), together accounting for 77% of total imports.

In terms of the main suppliers, the United States, with a CAGR of +48.2%, saw the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the average prophylactic medicaments containing insulin import price amounted to $X per ton, therefore, remained relatively stable against the previous year. In general, import price indicated a moderate increase from 2012 to 2022: its price increased at an average annual rate of +3.0% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, prophylactic medicaments containing insulin import price decreased by -1.6% against 2020 indices. The growth pace was the most rapid in 2014 when the average import price increased by 48%. As a result, import price reached the peak level of $X per ton. From 2015 to 2022, the average import prices failed to regain momentum.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Denmark ($X per ton), while the price for Brazil ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Denmark (+10.5%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :